155 related articles for article (PubMed ID: 36314011)
1. A meritorious integrated medical regimen for hepatic fibrosis and its complications
Ye Z; Huang Q; She Y; Hu Y; Wu M; Qin K; Li L; Zhang C; Zuo X; Wei A; Mao D; Ye Q
Front Med (Lausanne); 2022; 9():920062. PubMed ID: 36314011
[TBL] [Abstract][Full Text] [Related]
2. Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway.
Fu C; Zhang Y; Xi WJ; Xu K; Meng F; Ma T; Li W; Wu L; Chen Z
J Ethnopharmacol; 2023 May; 308():116191. PubMed ID: 36731809
[TBL] [Abstract][Full Text] [Related]
3. Dahuang zhechong pill ameliorates hepatic fibrosis by regulating gut microbiota and metabolites.
He X; Liang J; Li X; Wang Y; Zhang X; Chen D; Wu L; Wang S
J Ethnopharmacol; 2024 Mar; 321():117402. PubMed ID: 37967779
[TBL] [Abstract][Full Text] [Related]
4. Effect of Dahuang zhechong formula on liver fibrosis in patients with chronic hepatitis B: a meta-analysis.
Wei F; Lang Y; Gong D; Fan Y
Complement Ther Med; 2015 Feb; 23(1):129-38. PubMed ID: 25637160
[TBL] [Abstract][Full Text] [Related]
5. Effect of Dahuang Zhechong pills on long non-coding RNA growth arrest specific 5 in rat models of hepatic fibrosis.
Gong Z; Deng C; Xiao H; Peng Y; Hu G; Xiang T; Tao L; Zheng J
J Tradit Chin Med; 2018 Apr; 38(2):190-196. PubMed ID: 32186058
[TBL] [Abstract][Full Text] [Related]
6. Dahuang Zhechong pill attenuates CCl4-induced rat liver fibrosis via the PI3K-Akt signaling pathway.
Gong Z; Lin J; Zheng J; Wei L; Liu L; Peng Y; Liang W; Hu G
J Cell Biochem; 2020 Feb; 121(2):1431-1440. PubMed ID: 31502329
[TBL] [Abstract][Full Text] [Related]
7. [Effect of dahuang zhechong pill on transforming growth factor-beta 1 in hepatic stellate cells in rats].
Li L; Xu M; Liu ZL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Oct; 23(10):763-6. PubMed ID: 14626192
[TBL] [Abstract][Full Text] [Related]
8. Effects of Dahuang zhechong pill on doxorubicin-resistant SMMC-7721 xenografts in mice.
Wu L; Cao KX; Ni ZH; Li WD; Chen ZP; Cheng HB; Liu X
J Ethnopharmacol; 2018 Aug; 222():71-78. PubMed ID: 29609009
[TBL] [Abstract][Full Text] [Related]
9. Multi-material basis and multi-mechanisms of the Dahuang Zhechong pill for regulating Treg/Th1 balance in hepatocellular carcinoma.
Wu L; Yang FR; Xing ML; Lu SF; Chen HL; Yang QW; Zhang YT; Lu Y; Huang Y
Phytomedicine; 2022 Jun; 100():154055. PubMed ID: 35344716
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of influences of Biejiajian Pill combined with entecavir on serum liver fibrosis markers of compensatory period of hepatitis b cirrhosis: Protocol of systematic review and meta-analysis.
Zhang T; Yang Y; Wang B; Zheng X; Wang L; Feng X; Li G; Shi J; Cao N
Medicine (Baltimore); 2019 Dec; 98(51):e18458. PubMed ID: 31861022
[TBL] [Abstract][Full Text] [Related]
11. Clinical antitumor application and pharmacological mechanisms of Dahuang Zhechong Pill.
Tian Y; Ma B; Yu S; Li Y; Pei H; Tian S; Zhao X; Liu C; Zuo Z; Wang Z
Chin Herb Med; 2023 Apr; 15(2):169-180. PubMed ID: 37265776
[TBL] [Abstract][Full Text] [Related]
12. [Effect and mechanism of Dahuang Zhechong Pills in improving liver aging in rats by regulating ROS-mediated PI3K/Akt/FoxO4 signaling pathway].
Fu Y; Wu W; Wan YG; Yang HM; Tu Y; Liu SY; Fang QJ; Liu YL; Wang MZ; Huang H
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(11):3014-3021. PubMed ID: 37381959
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Dahuang Zhechong Pill in Silicosis: A Randomized Controlled Trial.
Tang WY; Liang JT; Wu J; Liu L; Lu MZ; He XY; Wu LJ; Jiang HY; Wang F; Meng X; Li SP
Evid Based Complement Alternat Med; 2021; 2021():4354054. PubMed ID: 34840587
[TBL] [Abstract][Full Text] [Related]
14. Dahuang Zhechong Pills Suppress Silicosis Fibrosis Progression via p38 MAPK/TGF-
Wu LJ; He XY; Wang WX; Liang J; Zhang YD; Liang JT; Chen DY
Evid Based Complement Alternat Med; 2021; 2021():6662261. PubMed ID: 33868442
[TBL] [Abstract][Full Text] [Related]
15. Dahuang Zhechong pills inhibit liver cancer growth in a mouse model by reversing Treg/Th1 balance.
Chen TT; DU SL; Wang SJ; Wu L; Yin L
Chin J Nat Med; 2022 Feb; 20(2):102-110. PubMed ID: 35279237
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the pharmacodynamic substances in dahuang zhechong pill that inhibit energy metabolism.
Ni ZH; Wu L; Cao KX; Zhang XQ; Wang DY; Zeng YW; Liang LL; Qiu XD; Guo RS; Cheng HB; Chen ZP
J Ethnopharmacol; 2020 Apr; 251():112332. PubMed ID: 31669443
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of nineteen compounds of Dahuang zhechong pill in rat plasma by UHPLC-MS/MS and its application in a pharmacokinetic study.
Wu L; Du S; Yang F; Ni Z; Chen Z; Liu X; Wang Y; Zhou Q; Li W; Qin K
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1151():122200. PubMed ID: 32526664
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of inhibiting proliferation of vascular smooth muscle cells by serum of rats treated with Dahuang Zhechong pill.
Zhang YH; Liu JT; Wen BY; Liu N
J Ethnopharmacol; 2009 Jul; 124(1):125-9. PubMed ID: 19527826
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of Huangqi Zhechong decoction on liver fibrosis in rat.
Dang SS; Jia XL; Cheng YA; Chen YR; Liu EQ; Li ZF
World J Gastroenterol; 2004 Aug; 10(15):2295-8. PubMed ID: 15259087
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Dahuang Zhechong Pill on expressions of tissue inhibitor of metalloproteinase-1 and plasminogen activator inhibitor-1 in rats with glomerulosclerosis].
Chen JH; Sun W; Zhou D; Gao K; He WM; Liu L
Zhong Xi Yi Jie He Xue Bao; 2008 May; 6(5):512-6. PubMed ID: 18471418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
